Statins Appear to Guard Against Liver Disease Progression

A large Swedish cohort study finds a significant protective association between statin use and liver disease progression in adults with non-cirrhotic chronic liver disease.

Related Keywords

New York ,United States ,Sweden ,Ohio ,Swedish ,William Carey ,Rajani Sharma ,Scottl Friedman ,Division Of Digestive ,Columbia University Irving Medical Center ,Icahn School Of Medicine At Mount Sinai ,International Classification Of Disease ,Division Of Liver Diseases ,Liver Diseases ,New York City ,Clinical Gastroenterology ,Medscape Medical ,Cleveland Clinic ,International Classification ,Therapeutic Discovery ,Icahn School ,Mount Sinai ,Biliary Disease ,Allbladder Disease ,Lipids ,Ipid Management ,Liver Disease ,Nonalcoholic Fatty Liver Disease ,Vafld ,Liver ,Metabolic Syndrome ,Hepatocellular Carcinoma ,Liver Cancer ,Dcc ,Hepatocellular Cancer ,Ancer Liver ,Ancer Hepatocellular ,Statin ,Lipid Lowering Drugs ,Rug Lipid Lowering ,Fatty Liver ,Teatorrhoeic Hepatosis ,Teatosis Hepatis ,Liver Fibrosis ,Liver Biopsy ,Hepatitis ,Ira ,